nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—SIGMAR1—Tamoxifen—pancreatic cancer	0.25	0.387	CbGbCtD
Donepezil—ACHE—Irinotecan—pancreatic cancer	0.174	0.269	CbGbCtD
Donepezil—CYP2C9—Tamoxifen—pancreatic cancer	0.0357	0.0552	CbGbCtD
Donepezil—CYP2D6—Tamoxifen—pancreatic cancer	0.0326	0.0505	CbGbCtD
Donepezil—CYP2D6—Erlotinib—pancreatic cancer	0.0278	0.0429	CbGbCtD
Donepezil—CYP2C9—Fluorouracil—pancreatic cancer	0.0263	0.0407	CbGbCtD
Donepezil—CYP3A4—Tamoxifen—pancreatic cancer	0.0208	0.0321	CbGbCtD
Donepezil—CYP3A4—Erlotinib—pancreatic cancer	0.0176	0.0273	CbGbCtD
Donepezil—CYP3A4—Irinotecan—pancreatic cancer	0.0159	0.0247	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—pancreatic cancer	0.0137	0.0212	CbGbCtD
Donepezil—CYP3A4—Docetaxel—pancreatic cancer	0.0117	0.0181	CbGbCtD
Donepezil—CYP3A4—Sunitinib—pancreatic cancer	0.0116	0.018	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—pancreatic cancer	0.00871	0.0135	CbGbCtD
Donepezil—HTR2A—enteric nervous system—pancreatic cancer	0.000649	0.476	CbGeAlD
Donepezil—HRH3—digestive system—pancreatic cancer	0.000193	0.141	CbGeAlD
Donepezil—ACHE—islet of Langerhans—pancreatic cancer	0.000174	0.127	CbGeAlD
Donepezil—Loss of consciousness—Docetaxel—pancreatic cancer	0.000133	0.000448	CcSEcCtD
Donepezil—Pancreatitis—Doxorubicin—pancreatic cancer	0.000133	0.000448	CcSEcCtD
Donepezil—Weight decreased—Epirubicin—pancreatic cancer	0.000133	0.000447	CcSEcCtD
Donepezil—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000132	0.000445	CcSEcCtD
Donepezil—Cough—Docetaxel—pancreatic cancer	0.000132	0.000445	CcSEcCtD
Donepezil—Angina pectoris—Doxorubicin—pancreatic cancer	0.000132	0.000445	CcSEcCtD
Donepezil—Hypersensitivity—Irinotecan—pancreatic cancer	0.000132	0.000444	CcSEcCtD
Donepezil—Pneumonia—Epirubicin—pancreatic cancer	0.000131	0.000443	CcSEcCtD
Donepezil—Convulsion—Docetaxel—pancreatic cancer	0.000131	0.000442	CcSEcCtD
Donepezil—Hypertension—Docetaxel—pancreatic cancer	0.000131	0.00044	CcSEcCtD
Donepezil—Infestation—Epirubicin—pancreatic cancer	0.000131	0.00044	CcSEcCtD
Donepezil—Infestation NOS—Epirubicin—pancreatic cancer	0.000131	0.00044	CcSEcCtD
Donepezil—Bronchitis—Doxorubicin—pancreatic cancer	0.00013	0.000439	CcSEcCtD
Donepezil—Myalgia—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Donepezil—Chest pain—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Donepezil—Arthralgia—Docetaxel—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Donepezil—Nausea—Sunitinib—pancreatic cancer	0.000129	0.000434	CcSEcCtD
Donepezil—Renal failure—Epirubicin—pancreatic cancer	0.000128	0.000433	CcSEcCtD
Donepezil—Asthenia—Irinotecan—pancreatic cancer	0.000128	0.000432	CcSEcCtD
Donepezil—Jaundice—Epirubicin—pancreatic cancer	0.000127	0.000429	CcSEcCtD
Donepezil—Conjunctivitis—Epirubicin—pancreatic cancer	0.000127	0.000428	CcSEcCtD
Donepezil—Urinary tract infection—Epirubicin—pancreatic cancer	0.000127	0.000428	CcSEcCtD
Donepezil—Dysuria—Doxorubicin—pancreatic cancer	0.000127	0.000427	CcSEcCtD
Donepezil—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000126	0.000425	CcSEcCtD
Donepezil—Dry mouth—Docetaxel—pancreatic cancer	0.000126	0.000425	CcSEcCtD
Donepezil—Sweating—Epirubicin—pancreatic cancer	0.000125	0.000422	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—pancreatic cancer	0.000125	0.000422	CcSEcCtD
Donepezil—Asthenia—Gemcitabine—pancreatic cancer	0.000125	0.000421	CcSEcCtD
Donepezil—Haematuria—Epirubicin—pancreatic cancer	0.000125	0.00042	CcSEcCtD
Donepezil—Confusional state—Docetaxel—pancreatic cancer	0.000125	0.00042	CcSEcCtD
Donepezil—Oedema—Docetaxel—pancreatic cancer	0.000123	0.000416	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—pancreatic cancer	0.000123	0.000416	CcSEcCtD
Donepezil—Epistaxis—Epirubicin—pancreatic cancer	0.000123	0.000415	CcSEcCtD
Donepezil—Pruritus—Gemcitabine—pancreatic cancer	0.000123	0.000415	CcSEcCtD
Donepezil—Infection—Docetaxel—pancreatic cancer	0.000123	0.000414	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—pancreatic cancer	0.000123	0.000413	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000122	0.000412	CcSEcCtD
Donepezil—Diarrhoea—Irinotecan—pancreatic cancer	0.000122	0.000412	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—pancreatic cancer	0.000122	0.00041	CcSEcCtD
Donepezil—Shock—Docetaxel—pancreatic cancer	0.000121	0.00041	CcSEcCtD
Donepezil—Nervous system disorder—Docetaxel—pancreatic cancer	0.000121	0.000408	CcSEcCtD
Donepezil—Pruritus—Fluorouracil—pancreatic cancer	0.000121	0.000408	CcSEcCtD
Donepezil—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000121	0.000408	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—pancreatic cancer	0.000121	0.000407	CcSEcCtD
Donepezil—Infestation—Doxorubicin—pancreatic cancer	0.000121	0.000407	CcSEcCtD
Donepezil—Bradycardia—Epirubicin—pancreatic cancer	0.000119	0.000402	CcSEcCtD
Donepezil—Diarrhoea—Gemcitabine—pancreatic cancer	0.000119	0.000401	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—pancreatic cancer	0.000119	0.0004	CcSEcCtD
Donepezil—Dizziness—Irinotecan—pancreatic cancer	0.000118	0.000398	CcSEcCtD
Donepezil—Haemoglobin—Epirubicin—pancreatic cancer	0.000118	0.000397	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—pancreatic cancer	0.000118	0.000397	CcSEcCtD
Donepezil—Anorexia—Docetaxel—pancreatic cancer	0.000118	0.000397	CcSEcCtD
Donepezil—Rhinitis—Epirubicin—pancreatic cancer	0.000118	0.000396	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000117	0.000396	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000117	0.000396	CcSEcCtD
Donepezil—Haemorrhage—Epirubicin—pancreatic cancer	0.000117	0.000395	CcSEcCtD
Donepezil—Hepatitis—Epirubicin—pancreatic cancer	0.000117	0.000395	CcSEcCtD
Donepezil—Diarrhoea—Fluorouracil—pancreatic cancer	0.000117	0.000395	CcSEcCtD
Donepezil—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000117	0.000393	CcSEcCtD
Donepezil—SIGMAR1—islet of Langerhans—pancreatic cancer	0.000117	0.0854	CbGeAlD
Donepezil—Pharyngitis—Epirubicin—pancreatic cancer	0.000116	0.000392	CcSEcCtD
Donepezil—Sweating—Doxorubicin—pancreatic cancer	0.000116	0.000391	CcSEcCtD
Donepezil—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000116	0.00039	CcSEcCtD
Donepezil—Oedema peripheral—Epirubicin—pancreatic cancer	0.000115	0.000389	CcSEcCtD
Donepezil—Hypotension—Docetaxel—pancreatic cancer	0.000115	0.000389	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—pancreatic cancer	0.000115	0.000388	CcSEcCtD
Donepezil—Urethral disorder—Epirubicin—pancreatic cancer	0.000115	0.000387	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—pancreatic cancer	0.000114	0.000384	CcSEcCtD
Donepezil—Vomiting—Irinotecan—pancreatic cancer	0.000114	0.000383	CcSEcCtD
Donepezil—Dizziness—Fluorouracil—pancreatic cancer	0.000113	0.000381	CcSEcCtD
Donepezil—Visual impairment—Epirubicin—pancreatic cancer	0.000113	0.000381	CcSEcCtD
Donepezil—Rash—Irinotecan—pancreatic cancer	0.000113	0.00038	CcSEcCtD
Donepezil—Dermatitis—Irinotecan—pancreatic cancer	0.000113	0.000379	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000113	0.000379	CcSEcCtD
Donepezil—Headache—Irinotecan—pancreatic cancer	0.000112	0.000377	CcSEcCtD
Donepezil—Insomnia—Docetaxel—pancreatic cancer	0.000112	0.000376	CcSEcCtD
Donepezil—Paraesthesia—Docetaxel—pancreatic cancer	0.000111	0.000374	CcSEcCtD
Donepezil—Vomiting—Gemcitabine—pancreatic cancer	0.000111	0.000373	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—pancreatic cancer	0.00011	0.000372	CcSEcCtD
Donepezil—Dyspnoea—Docetaxel—pancreatic cancer	0.00011	0.000371	CcSEcCtD
Donepezil—Somnolence—Docetaxel—pancreatic cancer	0.00011	0.00037	CcSEcCtD
Donepezil—Rash—Gemcitabine—pancreatic cancer	0.00011	0.00037	CcSEcCtD
Donepezil—Dermatitis—Gemcitabine—pancreatic cancer	0.00011	0.00037	CcSEcCtD
Donepezil—Tinnitus—Epirubicin—pancreatic cancer	0.000109	0.000368	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—pancreatic cancer	0.000109	0.000368	CcSEcCtD
Donepezil—Headache—Gemcitabine—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Donepezil—Vomiting—Fluorouracil—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—pancreatic cancer	0.000109	0.000367	CcSEcCtD
Donepezil—Dyspepsia—Docetaxel—pancreatic cancer	0.000109	0.000366	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—pancreatic cancer	0.000108	0.000366	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—pancreatic cancer	0.000108	0.000366	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000108	0.000364	CcSEcCtD
Donepezil—Rash—Fluorouracil—pancreatic cancer	0.000108	0.000364	CcSEcCtD
Donepezil—Dermatitis—Fluorouracil—pancreatic cancer	0.000108	0.000363	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—pancreatic cancer	0.000108	0.000363	CcSEcCtD
Donepezil—Decreased appetite—Docetaxel—pancreatic cancer	0.000107	0.000362	CcSEcCtD
Donepezil—Headache—Fluorouracil—pancreatic cancer	0.000107	0.000361	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000107	0.000361	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000107	0.00036	CcSEcCtD
Donepezil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000107	0.000359	CcSEcCtD
Donepezil—Fatigue—Docetaxel—pancreatic cancer	0.000106	0.000359	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—pancreatic cancer	0.000106	0.000358	CcSEcCtD
Donepezil—Nausea—Irinotecan—pancreatic cancer	0.000106	0.000358	CcSEcCtD
Donepezil—Constipation—Docetaxel—pancreatic cancer	0.000106	0.000356	CcSEcCtD
Donepezil—Pain—Docetaxel—pancreatic cancer	0.000106	0.000356	CcSEcCtD
Donepezil—Chills—Epirubicin—pancreatic cancer	0.000105	0.000355	CcSEcCtD
Donepezil—Arrhythmia—Epirubicin—pancreatic cancer	0.000105	0.000353	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—pancreatic cancer	0.000105	0.000352	CcSEcCtD
Donepezil—Alopecia—Epirubicin—pancreatic cancer	0.000104	0.000349	CcSEcCtD
Donepezil—Nausea—Gemcitabine—pancreatic cancer	0.000103	0.000348	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—pancreatic cancer	0.000103	0.000346	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Donepezil—Erythema—Epirubicin—pancreatic cancer	0.000102	0.000344	CcSEcCtD
Donepezil—Feeling abnormal—Docetaxel—pancreatic cancer	0.000102	0.000343	CcSEcCtD
Donepezil—Nausea—Fluorouracil—pancreatic cancer	0.000102	0.000343	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—pancreatic cancer	0.000101	0.000341	CcSEcCtD
Donepezil—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000101	0.00034	CcSEcCtD
Donepezil—Flatulence—Epirubicin—pancreatic cancer	0.000101	0.000339	CcSEcCtD
Donepezil—Tension—Epirubicin—pancreatic cancer	0.0001	0.000338	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—pancreatic cancer	9.99e-05	0.000337	CcSEcCtD
Donepezil—Nervousness—Epirubicin—pancreatic cancer	9.91e-05	0.000334	CcSEcCtD
Donepezil—Back pain—Epirubicin—pancreatic cancer	9.87e-05	0.000333	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—pancreatic cancer	9.81e-05	0.000331	CcSEcCtD
Donepezil—Abdominal pain—Docetaxel—pancreatic cancer	9.76e-05	0.000329	CcSEcCtD
Donepezil—Body temperature increased—Docetaxel—pancreatic cancer	9.76e-05	0.000329	CcSEcCtD
Donepezil—Chills—Doxorubicin—pancreatic cancer	9.73e-05	0.000328	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—pancreatic cancer	9.69e-05	0.000327	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—pancreatic cancer	9.62e-05	0.000324	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—pancreatic cancer	9.59e-05	0.000323	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—pancreatic cancer	9.5e-05	0.00032	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—pancreatic cancer	9.47e-05	0.000319	CcSEcCtD
Donepezil—Erythema—Doxorubicin—pancreatic cancer	9.44e-05	0.000318	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—pancreatic cancer	9.44e-05	0.000318	CcSEcCtD
Donepezil—Anaemia—Epirubicin—pancreatic cancer	9.43e-05	0.000318	CcSEcCtD
Donepezil—Agitation—Epirubicin—pancreatic cancer	9.38e-05	0.000316	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—pancreatic cancer	9.31e-05	0.000314	CcSEcCtD
Donepezil—Tension—Doxorubicin—pancreatic cancer	9.27e-05	0.000312	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—pancreatic cancer	9.25e-05	0.000312	CcSEcCtD
Donepezil—Malaise—Epirubicin—pancreatic cancer	9.2e-05	0.00031	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—pancreatic cancer	9.17e-05	0.000309	CcSEcCtD
Donepezil—Vertigo—Epirubicin—pancreatic cancer	9.17e-05	0.000309	CcSEcCtD
Donepezil—Syncope—Epirubicin—pancreatic cancer	9.15e-05	0.000309	CcSEcCtD
Donepezil—Back pain—Doxorubicin—pancreatic cancer	9.13e-05	0.000308	CcSEcCtD
Donepezil—Hypersensitivity—Docetaxel—pancreatic cancer	9.1e-05	0.000307	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—pancreatic cancer	9.08e-05	0.000306	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—pancreatic cancer	8.97e-05	0.000302	CcSEcCtD
Donepezil—Cough—Epirubicin—pancreatic cancer	8.91e-05	0.0003	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—pancreatic cancer	8.9e-05	0.0003	CcSEcCtD
Donepezil—Asthenia—Docetaxel—pancreatic cancer	8.86e-05	0.000299	CcSEcCtD
Donepezil—Convulsion—Epirubicin—pancreatic cancer	8.84e-05	0.000298	CcSEcCtD
Donepezil—Hypertension—Epirubicin—pancreatic cancer	8.81e-05	0.000297	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.76e-05	0.000295	CcSEcCtD
Donepezil—Pruritus—Docetaxel—pancreatic cancer	8.74e-05	0.000295	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—pancreatic cancer	8.73e-05	0.000294	CcSEcCtD
Donepezil—Myalgia—Epirubicin—pancreatic cancer	8.69e-05	0.000293	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—pancreatic cancer	8.69e-05	0.000293	CcSEcCtD
Donepezil—Chest pain—Epirubicin—pancreatic cancer	8.69e-05	0.000293	CcSEcCtD
Donepezil—Agitation—Doxorubicin—pancreatic cancer	8.68e-05	0.000293	CcSEcCtD
Donepezil—Anxiety—Epirubicin—pancreatic cancer	8.66e-05	0.000292	CcSEcCtD
Donepezil—Discomfort—Epirubicin—pancreatic cancer	8.58e-05	0.000289	CcSEcCtD
Donepezil—Malaise—Doxorubicin—pancreatic cancer	8.52e-05	0.000287	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—pancreatic cancer	8.5e-05	0.000286	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—pancreatic cancer	8.48e-05	0.000286	CcSEcCtD
Donepezil—Syncope—Doxorubicin—pancreatic cancer	8.47e-05	0.000285	CcSEcCtD
Donepezil—Diarrhoea—Docetaxel—pancreatic cancer	8.45e-05	0.000285	CcSEcCtD
Donepezil—Confusional state—Epirubicin—pancreatic cancer	8.4e-05	0.000283	CcSEcCtD
Donepezil—Oedema—Epirubicin—pancreatic cancer	8.33e-05	0.000281	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—pancreatic cancer	8.3e-05	0.00028	CcSEcCtD
Donepezil—Infection—Epirubicin—pancreatic cancer	8.27e-05	0.000279	CcSEcCtD
Donepezil—Cough—Doxorubicin—pancreatic cancer	8.24e-05	0.000278	CcSEcCtD
Donepezil—Shock—Epirubicin—pancreatic cancer	8.19e-05	0.000276	CcSEcCtD
Donepezil—SIGMAR1—pancreas—pancreatic cancer	8.19e-05	0.06	CbGeAlD
Donepezil—Convulsion—Doxorubicin—pancreatic cancer	8.18e-05	0.000276	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—pancreatic cancer	8.17e-05	0.000275	CcSEcCtD
Donepezil—Dizziness—Docetaxel—pancreatic cancer	8.17e-05	0.000275	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—pancreatic cancer	8.16e-05	0.000275	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—pancreatic cancer	8.15e-05	0.000275	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—pancreatic cancer	8.05e-05	0.000271	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—pancreatic cancer	8.04e-05	0.000271	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—pancreatic cancer	8.04e-05	0.000271	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—pancreatic cancer	8.04e-05	0.000271	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—pancreatic cancer	8.01e-05	0.00027	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—pancreatic cancer	7.94e-05	0.000268	CcSEcCtD
Donepezil—Anorexia—Epirubicin—pancreatic cancer	7.94e-05	0.000268	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—pancreatic cancer	7.86e-05	0.000265	CcSEcCtD
Donepezil—Vomiting—Docetaxel—pancreatic cancer	7.85e-05	0.000265	CcSEcCtD
Donepezil—Rash—Docetaxel—pancreatic cancer	7.79e-05	0.000262	CcSEcCtD
Donepezil—Hypotension—Epirubicin—pancreatic cancer	7.78e-05	0.000262	CcSEcCtD
Donepezil—Dermatitis—Docetaxel—pancreatic cancer	7.78e-05	0.000262	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—pancreatic cancer	7.77e-05	0.000262	CcSEcCtD
Donepezil—Headache—Docetaxel—pancreatic cancer	7.74e-05	0.000261	CcSEcCtD
Donepezil—Oedema—Doxorubicin—pancreatic cancer	7.71e-05	0.00026	CcSEcCtD
Donepezil—Infection—Doxorubicin—pancreatic cancer	7.66e-05	0.000258	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.59e-05	0.000256	CcSEcCtD
Donepezil—Shock—Doxorubicin—pancreatic cancer	7.58e-05	0.000256	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—pancreatic cancer	7.56e-05	0.000255	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.55e-05	0.000254	CcSEcCtD
Donepezil—Insomnia—Epirubicin—pancreatic cancer	7.53e-05	0.000254	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—pancreatic cancer	7.48e-05	0.000252	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.45e-05	0.000251	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—pancreatic cancer	7.43e-05	0.00025	CcSEcCtD
Donepezil—Somnolence—Epirubicin—pancreatic cancer	7.4e-05	0.00025	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—pancreatic cancer	7.35e-05	0.000248	CcSEcCtD
Donepezil—Nausea—Docetaxel—pancreatic cancer	7.34e-05	0.000247	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—pancreatic cancer	7.33e-05	0.000247	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—pancreatic cancer	7.24e-05	0.000244	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—pancreatic cancer	7.2e-05	0.000243	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.19e-05	0.000242	CcSEcCtD
Donepezil—Fatigue—Epirubicin—pancreatic cancer	7.18e-05	0.000242	CcSEcCtD
Donepezil—Pain—Epirubicin—pancreatic cancer	7.12e-05	0.00024	CcSEcCtD
Donepezil—Constipation—Epirubicin—pancreatic cancer	7.12e-05	0.00024	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.02e-05	0.000237	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—pancreatic cancer	6.97e-05	0.000235	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—pancreatic cancer	6.92e-05	0.000233	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—pancreatic cancer	6.87e-05	0.000232	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—pancreatic cancer	6.86e-05	0.000231	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—pancreatic cancer	6.85e-05	0.000231	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.81e-05	0.00023	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—pancreatic cancer	6.78e-05	0.000229	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—pancreatic cancer	6.7e-05	0.000226	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.65e-05	0.000224	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—pancreatic cancer	6.64e-05	0.000224	CcSEcCtD
Donepezil—Urticaria—Epirubicin—pancreatic cancer	6.62e-05	0.000223	CcSEcCtD
Donepezil—Constipation—Doxorubicin—pancreatic cancer	6.59e-05	0.000222	CcSEcCtD
Donepezil—Pain—Doxorubicin—pancreatic cancer	6.59e-05	0.000222	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—pancreatic cancer	6.58e-05	0.000222	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—pancreatic cancer	6.58e-05	0.000222	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—pancreatic cancer	6.35e-05	0.000214	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.3e-05	0.000212	CcSEcCtD
Donepezil—Hypersensitivity—Epirubicin—pancreatic cancer	6.14e-05	0.000207	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—pancreatic cancer	6.12e-05	0.000206	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—pancreatic cancer	6.09e-05	0.000205	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—pancreatic cancer	6.09e-05	0.000205	CcSEcCtD
Donepezil—Asthenia—Epirubicin—pancreatic cancer	5.98e-05	0.000201	CcSEcCtD
Donepezil—Pruritus—Epirubicin—pancreatic cancer	5.89e-05	0.000199	CcSEcCtD
Donepezil—Diarrhoea—Epirubicin—pancreatic cancer	5.7e-05	0.000192	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—pancreatic cancer	5.68e-05	0.000191	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—pancreatic cancer	5.53e-05	0.000186	CcSEcCtD
Donepezil—Dizziness—Epirubicin—pancreatic cancer	5.51e-05	0.000186	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—pancreatic cancer	5.45e-05	0.000184	CcSEcCtD
Donepezil—Vomiting—Epirubicin—pancreatic cancer	5.3e-05	0.000179	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—pancreatic cancer	5.27e-05	0.000178	CcSEcCtD
Donepezil—Rash—Epirubicin—pancreatic cancer	5.25e-05	0.000177	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—pancreatic cancer	5.25e-05	0.000177	CcSEcCtD
Donepezil—Headache—Epirubicin—pancreatic cancer	5.22e-05	0.000176	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—pancreatic cancer	5.1e-05	0.000172	CcSEcCtD
Donepezil—Nausea—Epirubicin—pancreatic cancer	4.95e-05	0.000167	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—pancreatic cancer	4.9e-05	0.000165	CcSEcCtD
Donepezil—Rash—Doxorubicin—pancreatic cancer	4.86e-05	0.000164	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—pancreatic cancer	4.85e-05	0.000164	CcSEcCtD
Donepezil—Headache—Doxorubicin—pancreatic cancer	4.83e-05	0.000163	CcSEcCtD
Donepezil—Nausea—Doxorubicin—pancreatic cancer	4.58e-05	0.000154	CcSEcCtD
Donepezil—CYP2C9—digestive system—pancreatic cancer	4.52e-05	0.0331	CbGeAlD
Donepezil—HTR2A—Signaling by GPCR—SCT—pancreatic cancer	4.51e-05	0.000811	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.43e-05	0.000796	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.4e-05	0.000791	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.39e-05	0.000788	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PRLHR—pancreatic cancer	4.32e-05	0.000776	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCK—pancreatic cancer	4.31e-05	0.000774	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GLP1R—pancreatic cancer	4.29e-05	0.00077	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.28e-05	0.00077	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SMAD4—pancreatic cancer	4.27e-05	0.000768	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.23e-05	0.00076	CbGpPWpGaD
Donepezil—ACHE—Metabolism—DPYD—pancreatic cancer	4.22e-05	0.000758	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CNR2—pancreatic cancer	4.2e-05	0.000754	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GLP1R—pancreatic cancer	4.2e-05	0.000754	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HES1—pancreatic cancer	4.17e-05	0.00075	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CCKAR—pancreatic cancer	4.13e-05	0.000742	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IAPP—pancreatic cancer	4.09e-05	0.000736	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ZNRF3—pancreatic cancer	4.06e-05	0.000729	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ACVR1B—pancreatic cancer	4.06e-05	0.000729	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC2A2—pancreatic cancer	4e-05	0.000719	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CB—pancreatic cancer	4e-05	0.000718	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.96e-05	0.000711	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.95e-05	0.00071	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.95e-05	0.00071	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PTHLH—pancreatic cancer	3.93e-05	0.000706	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL8—pancreatic cancer	3.84e-05	0.00069	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.82e-05	0.000687	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—SHH—pancreatic cancer	3.76e-05	0.000676	CbGpPWpGaD
Donepezil—HTR2A—digestive system—pancreatic cancer	3.73e-05	0.0273	CbGeAlD
Donepezil—HTR2A—Signaling by GPCR—IAPP—pancreatic cancer	3.72e-05	0.000668	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SSTR3—pancreatic cancer	3.67e-05	0.00066	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DTX1—pancreatic cancer	3.67e-05	0.00066	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TERT—pancreatic cancer	3.66e-05	0.000657	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.62e-05	0.00065	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—SST—pancreatic cancer	3.59e-05	0.000646	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTHLH—pancreatic cancer	3.57e-05	0.000641	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTCH1—pancreatic cancer	3.57e-05	0.000641	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	3.52e-05	0.000633	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SSTR1—pancreatic cancer	3.52e-05	0.000632	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HIF1A—pancreatic cancer	3.5e-05	0.000628	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TSC2—pancreatic cancer	3.49e-05	0.000627	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.48e-05	0.000625	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPY—pancreatic cancer	3.45e-05	0.00062	CbGpPWpGaD
Donepezil—CYP3A4—digestive system—pancreatic cancer	3.45e-05	0.0253	CbGeAlD
Donepezil—HRH3—Signaling Pathways—APOE—pancreatic cancer	3.41e-05	0.000613	CbGpPWpGaD
Donepezil—CYP2D6—digestive system—pancreatic cancer	3.39e-05	0.0249	CbGeAlD
Donepezil—HTR2A—Signaling Pathways—SSTR2—pancreatic cancer	3.39e-05	0.000609	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KDR—pancreatic cancer	3.34e-05	0.000601	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CNR1—pancreatic cancer	3.32e-05	0.000596	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCKBR—pancreatic cancer	3.27e-05	0.000588	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—SST—pancreatic cancer	3.26e-05	0.000586	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.25e-05	0.000585	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	3.21e-05	0.000577	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GCG—pancreatic cancer	3.2e-05	0.000576	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NFKBIA—pancreatic cancer	3.18e-05	0.000572	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOTCH1—pancreatic cancer	3.15e-05	0.000566	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	3.12e-05	0.00056	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CD44—pancreatic cancer	3.1e-05	0.000557	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CG—pancreatic cancer	3.08e-05	0.000554	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—NRAS—pancreatic cancer	3.08e-05	0.000554	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GLI1—pancreatic cancer	3.08e-05	0.000553	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DTX4—pancreatic cancer	3.08e-05	0.000553	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AGTR1—pancreatic cancer	3.06e-05	0.000549	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGF—pancreatic cancer	3.05e-05	0.000547	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	3.03e-05	0.000545	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.03e-05	0.000545	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	3.03e-05	0.000545	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—HRAS—pancreatic cancer	3.03e-05	0.000544	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CNR1—pancreatic cancer	3.01e-05	0.000541	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.01e-05	0.00054	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP2R5B—pancreatic cancer	2.99e-05	0.000538	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRP1—pancreatic cancer	2.99e-05	0.000538	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GCG—pancreatic cancer	2.97e-05	0.000534	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GCG—pancreatic cancer	2.91e-05	0.000523	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HEY2—pancreatic cancer	2.88e-05	0.000518	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.88e-05	0.000517	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.85e-05	0.000513	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GAST—pancreatic cancer	2.81e-05	0.000505	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—pancreatic cancer	2.81e-05	0.000504	CbGpPWpGaD
Donepezil—ACHE—Metabolism—STK11—pancreatic cancer	2.79e-05	0.000502	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	2.79e-05	0.000501	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AGTR1—pancreatic cancer	2.78e-05	0.000499	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CD—pancreatic cancer	2.71e-05	0.000487	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.68e-05	0.000482	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SCT—pancreatic cancer	2.67e-05	0.000479	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HEY1—pancreatic cancer	2.67e-05	0.000479	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—pancreatic cancer	2.65e-05	0.000477	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.62e-05	0.000471	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	2.58e-05	0.000463	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCK—pancreatic cancer	2.54e-05	0.000457	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	2.52e-05	0.000453	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.49e-05	0.000448	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CNR2—pancreatic cancer	2.48e-05	0.000445	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GLP1R—pancreatic cancer	2.48e-05	0.000445	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—pancreatic cancer	2.48e-05	0.000445	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ARG2—pancreatic cancer	2.47e-05	0.000444	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCKAR—pancreatic cancer	2.44e-05	0.000438	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.44e-05	0.000438	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TYMS—pancreatic cancer	2.4e-05	0.000432	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAG2—pancreatic cancer	2.37e-05	0.000425	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CB—pancreatic cancer	2.36e-05	0.000424	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MEN1—pancreatic cancer	2.33e-05	0.000419	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.32e-05	0.000418	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—pancreatic cancer	2.27e-05	0.000408	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HRAS—pancreatic cancer	2.25e-05	0.000405	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SHH—pancreatic cancer	2.22e-05	0.0004	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH4—pancreatic cancer	2.21e-05	0.000397	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IAPP—pancreatic cancer	2.2e-05	0.000395	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—pancreatic cancer	2.19e-05	0.000394	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.18e-05	0.000392	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—pancreatic cancer	2.17e-05	0.00039	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.16e-05	0.000388	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—pancreatic cancer	2.11e-05	0.00038	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTHLH—pancreatic cancer	2.11e-05	0.000379	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTCH1—pancreatic cancer	2.11e-05	0.000379	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CTNNB1—pancreatic cancer	2.09e-05	0.000376	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—pancreatic cancer	2.05e-05	0.000369	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—pancreatic cancer	2.04e-05	0.000367	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—pancreatic cancer	1.99e-05	0.000358	CbGpPWpGaD
Donepezil—ACHE—Metabolism—APOE—pancreatic cancer	1.95e-05	0.000351	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SST—pancreatic cancer	1.93e-05	0.000346	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	1.9e-05	0.000342	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—pancreatic cancer	1.89e-05	0.00034	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAG1—pancreatic cancer	1.89e-05	0.000339	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.88e-05	0.000338	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH3—pancreatic cancer	1.88e-05	0.000338	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.85e-05	0.000332	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—pancreatic cancer	1.84e-05	0.000331	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—pancreatic cancer	1.82e-05	0.000328	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NRAS—pancreatic cancer	1.82e-05	0.000327	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.78e-05	0.000321	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CNR1—pancreatic cancer	1.78e-05	0.00032	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—pancreatic cancer	1.76e-05	0.000317	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.76e-05	0.000316	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.74e-05	0.000313	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.73e-05	0.000311	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—pancreatic cancer	1.73e-05	0.00031	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GCG—pancreatic cancer	1.72e-05	0.000309	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.71e-05	0.000308	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—pancreatic cancer	1.7e-05	0.000306	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—pancreatic cancer	1.7e-05	0.000305	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TGFB1—pancreatic cancer	1.69e-05	0.000304	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.67e-05	0.0003	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—pancreatic cancer	1.66e-05	0.000298	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.64e-05	0.000295	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AGTR1—pancreatic cancer	1.64e-05	0.000295	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.63e-05	0.000293	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.63e-05	0.000292	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STK11—pancreatic cancer	1.62e-05	0.00029	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.61e-05	0.000289	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—pancreatic cancer	1.57e-05	0.000282	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.55e-05	0.000279	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—pancreatic cancer	1.55e-05	0.000279	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.52e-05	0.000273	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.46e-05	0.000262	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—pancreatic cancer	1.44e-05	0.000259	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.43e-05	0.000256	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.42e-05	0.000254	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SMAD4—pancreatic cancer	1.42e-05	0.000254	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.4e-05	0.000252	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—pancreatic cancer	1.39e-05	0.00025	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—pancreatic cancer	1.38e-05	0.000248	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—pancreatic cancer	1.35e-05	0.000243	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—pancreatic cancer	1.34e-05	0.000241	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—pancreatic cancer	1.33e-05	0.000239	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.32e-05	0.000238	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.27e-05	0.000228	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CD44—pancreatic cancer	1.27e-05	0.000228	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CD44—pancreatic cancer	1.26e-05	0.000226	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.23e-05	0.000222	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.22e-05	0.00022	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GCG—pancreatic cancer	1.22e-05	0.000219	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—pancreatic cancer	1.21e-05	0.000218	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GCG—pancreatic cancer	1.21e-05	0.000217	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—pancreatic cancer	1.18e-05	0.000211	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—pancreatic cancer	1.17e-05	0.00021	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	1.16e-05	0.000208	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	1.15e-05	0.000208	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.15e-05	0.000206	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—STK11—pancreatic cancer	1.15e-05	0.000206	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—STK11—pancreatic cancer	1.14e-05	0.000204	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.13e-05	0.000203	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APOE—pancreatic cancer	1.13e-05	0.000203	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—pancreatic cancer	1.11e-05	0.000199	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.07e-05	0.000193	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.07e-05	0.000192	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.05e-05	0.000189	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.04e-05	0.000187	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.02e-05	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	1.02e-05	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGF—pancreatic cancer	1.01e-05	0.000181	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMS—pancreatic cancer	9.85e-06	0.000177	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMS—pancreatic cancer	9.77e-06	0.000176	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	9.29e-06	0.000167	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	8.97e-06	0.000161	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.88e-06	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	8.78e-06	0.000158	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CD44—pancreatic cancer	8.31e-06	0.000149	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—pancreatic cancer	8.24e-06	0.000148	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.07e-06	0.000145	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APOE—pancreatic cancer	8.01e-06	0.000144	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GCG—pancreatic cancer	7.97e-06	0.000143	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APOE—pancreatic cancer	7.94e-06	0.000143	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.82e-06	0.00014	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.52e-06	0.000135	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	7.51e-06	0.000135	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—STK11—pancreatic cancer	7.49e-06	0.000135	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	7.46e-06	0.000134	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	7.26e-06	0.00013	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	7.23e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	7.19e-06	0.000129	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	7.17e-06	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	7e-06	0.000126	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—pancreatic cancer	6.98e-06	0.000125	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.93e-06	0.000125	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—pancreatic cancer	6.92e-06	0.000124	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	6.79e-06	0.000122	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	6.75e-06	0.000121	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—pancreatic cancer	6.73e-06	0.000121	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	6.59e-06	0.000118	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.44e-06	0.000116	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	6.36e-06	0.000114	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	6.3e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—pancreatic cancer	6.26e-06	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	6.1e-06	0.00011	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	6.04e-06	0.000109	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	6.03e-06	0.000108	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—pancreatic cancer	5.61e-06	0.000101	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	5.6e-06	0.000101	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.54e-06	9.96e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	5.49e-06	9.87e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—pancreatic cancer	5.49e-06	9.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	5.49e-06	9.87e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—pancreatic cancer	5.44e-06	9.78e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APOE—pancreatic cancer	5.24e-06	9.41e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	5.19e-06	9.32e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.79e-06	8.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.76e-06	8.56e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—pancreatic cancer	4.75e-06	8.53e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.73e-06	8.5e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—pancreatic cancer	4.61e-06	8.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.56e-06	8.2e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	4.41e-06	7.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.16e-06	7.47e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.89e-06	6.99e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.62e-06	6.51e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.59e-06	6.45e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.38e-06	6.07e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	3.35e-06	6.02e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.13e-06	5.63e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.76e-06	4.96e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.74e-06	4.92e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.21e-06	3.97e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.8e-06	3.24e-05	CbGpPWpGaD
